Healthcare: 3 Beaten-Up Biotechs -- Are They Buys?
- Author
- The Motley Fool
- Published
- Wed 09 Oct 2019
- Episode Link
- https://wherethemoneyis.libsyn.com/healthcare-3-beaten-up-biotechs-are-they-buys
Here's why post-approval setbacks have caused Puma Biotechnology, Clovis Oncology, and Regenxbio shares to tumble, and if any of these stocks are finally worth buying. Stocks: PBYI, CLVS, RGNX
Check out more of our content here:
